Youmanitarian
Youmanitarian 11 Jun 2021

Suivant

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Vues

Defining Progression in Metastatic Kidney Cancer

10 Vues
TAKE ACTION
Donations would go to support charities for Comment styliser

Panelists Robert A. Figlin, MD; Michael R. Harrison, MD; David I. Quinn, MBBS, PhD; and Eric Jonasch, MD, discuss defining clinical progression and optimizing use of VEGF TKI therapy to achieve the highest dose intensity before switching in patients with metastatic kidney cancer.

Montre plus
More ways to take action
Explore ways that you can help bring a solution to this issue.

Suivant

Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
24 May 2023
Understand Cancer & Reduce Cancer Risk | Dr. Peter Attia & Dr. Andrew Huberman
uchetex · 13 Vues